Denial Prevention vs. Denial Recovery: Where Should You Invest?

There are many techniques through which denials that are preventable can be decreased by investing in prevention and yet keeping an efficient claim recovery process in case a denial takes place. The right balance will depend on the pattern of denials, staff levels, payers’ mix, and the results of recovery efforts. In 2026, new payer requirements and coding necessitate it.

Claims denials are faster and more automated than ever before. Federal regulations are influencing prior authorization policies. Coding changes come out quarterly. Billing staff are under pressure. Investing in the right place is more important than ever before.

This guide compares denial prevention and denial recovery, explains the economics behind each, and offers a framework for deciding how to split your resources.

What Is Denial Prevention?

Denial prevention is the set of processes, people, and technology that stop claim denials before a claim is ever submitted. It focuses on getting every claim right the first time.

Typical denial prevention activities include:

• Verifying eligibility and benefits before the visit
• Confirming prior authorization requirements and obtaining approvals
• Capturing complete and accurate patient demographics
• Coding accurately with current CPT, ICD-10-CM, and HCPCS Level II codes
• Applying the right modifiers and checking NCCI edits
• Ensuring documentation supports medical necessity
• Scrubbing claims against payer-specific rules before submission

What Is Denial Recovery?

Denial recovery, which is sometimes referred to as denial management or denial resolution, is the process of recovering payment for the claims which have been denied. It starts when there is a denial on the ERA and concludes either with payment of the claim or its write-off.

Common denial recovery tasks include review of CARC and RARC codes, claim correction, re-submission of the claims, filing of reconsideration requests, filing appeals and keeping track of all claims relative to payer appeal deadlines.

The Economics: Why Preventable Denials Cost So Much

Each denial has two costs attached to it: the cost of the delay in payment and the cost of fixing the denial. The process of recovery includes investigating the denial, compiling evidence, reversing or contesting the denial, and contacting the other side repeatedly. This cost is for revenues that have already been generated.

However, the major cost lies in the revenue that will not be recovered. Industry studies have consistently shown that a substantial portion of denials is never recovered because the team runs out of time or the denial exceeds the appeals/ timely filing deadline. Even a good recovery team cannot reverse all denials.

Most of these losses come from preventable denials: denials caused by errors or gaps your practice could have caught before submission. Common examples include:

• Eligibility and coverage errors (for example, an inactive plan or wrong payer)
• Missing or invalid prior authorization (often CARC CO-197)
• Missing or incomplete information on the claim (CARC CO-16)
• Coding errors, such as deleted codes, incorrect modifiers, or unbundling
• Documentation that does not support medical necessity (CARC CO-50)
• Duplicate claims and late filing (CARC CO-29)

When the root cause sits inside your own workflow, denial prevention is almost always cheaper than recovery.

First-Pass Yield: The Metric That Connects Both

First-pass yield (FPY), also called first-pass resolution rate, is the percentage of claims paid in full on the first submission, with no rework, resubmission, or appeal.

Formula: (Claims paid on first submission ÷ Total claims submitted) × 100

There is a difference between the first pass yield and the clean claims rate. While a clean claim will be able to pass both payer and clearinghouse front end edits, it could still get denied when the claim is being adjudicated. The first pass yield will tell you whether the claim has been paid without any other effort, which means it is the best indicator of your denial prevention efforts.

Each percentage point you add to your first pass yield means that the denial recovery team doesn’t have to take care of that claim.

Where Denial Prevention Investment Pays Off in 2026

Denial prevention works best when it targets the specific root causes behind your own denials. Four areas deserve particular attention this year.

Front-End Eligibility and Registration

Registration and eligibility mistakes can be the most frequent causes of avoidable denials. Real-time eligibility verification, insurance identification, and correct demographic data collection before the appointment and during check-in can prevent many denials even before the patient is examined.

Prior Authorization Management

In 2026, prior authorization continues to be one of the leading sources of denials. The 72-hour expedited and seven-calendar-day standard deadlines apply to specified impacted payers for medical items and services, excluding drugs. Qualified health plan issuers on federally facilitated exchanges are excluded from these new decision-timeframe requirements. Prior authorization APIs are mandatory from 2027.

The Centers for Medicare & Medicaid Services Waste and Inappropriate Services Reduction (WISeR) Model started in January 2026 and will end in 2031 in Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. This model pertains to certain services that are covered by Original Medicare and not all Medicare services. Prior authorization requests may be made by providers and suppliers for any of the covered services under this model, or claims may be reviewed using pre-payment medical review for those not submitting authorization requests.

A reliable authorization workflow, taking into account requirements per payer and service, is one of the best return-on-investment prevention measures for denials.

Coding Accuracy and Documentation

Each year on January 1st, the CPT codes are revised, each year on October 1st, the ICD-10-CM codes, and the HCPCS Level II codes and NCCI edits are updated quarterly. A code which was appropriate for use in the previous year might now have been deleted or need to be more specific.

The use of AI-assisted coding software will check the codes, modifiers, and diagnosis coding according to current guidelines and the medical record before being submitted. This is one of the areas where denial prevention through coding shows its value in first-pass yield.

Predictive Claim Scrubbing

Traditional scrubbers catch formatting errors. Predictive tools go further, using your own denial history and payer behavior to flag claims with a high likelihood of denial so staff can fix them before submission.

Where Denial Recovery and Claim Appeals Still Matter

Even the strongest denial prevention program will not eliminate every denial. Some are outside your control: payer processing errors, retroactive eligibility changes, shifting coverage policies, and clinical judgment disputes. These still require skilled denial recovery.

• Recovery is most valuable in the following instances:
• High-denomination denials: Surgery, oncology, infusions, and other inpatient-related denials are usually worthy of appeal despite how time-consuming it may be.
• Medical necessity denials: Claim appeals backed up by clinical documentation and the payer's plan itself can reverse medical necessity denials.
• Claim errors and underpayments: Claims that have been denied or underpaid due to the fulfillment of all contract terms must be pursued.
• Systematic payer actions: Denials of the same service on multiple occasions merit action by going through provider relations or renegotiating contracts.

With respect to Original Medicare fee-for-service appeals, the first level of appeal (called a redetermination) needs to be filed generally within 120 days of the receipt of the notice of the initial determination. The second level of appeal (reconsideration) needs to be filed generally within 180 days of the receipt of the redetermination.

Tailwind for recovery in 2026: Due to the fact that CMS-0057-F mandates that payers provide specific reasons why they deny coverage, the recovery team is better equipped with information required to build the case. Moreover, AI technology can develop appeal letters in connection with the clinical record and payer policy, thus substantially speeding up claims appeal process.

The most important thing to remember is that recovery is absolutely crucial, but it is reactive. Every minute you spend recovering a denied claim is a minute wasted on solving an existing issue.

Denial Prevention vs. Denial Recovery at a Glance

How to Decide Where to Invest

Budget allocations vary widely. Just because something works for an organization does not mean that it will also work for other organizations. These are the four steps which need to be taken into account:

• Category your reasons for denials. Do an analysis for at least three to six months on the reasons, CARCs, payers, providers, services, and denial stages for your denials. Classify your denials as preventable and non-preventable.
• Determine your starting point. You need to determine your first pass yield, denial rates, denial overturn rates, and days in A/R, so that you understand the effects of changes you have made.
• Begin by making investments in prevention of denials. In case most of your denials are due to eligibility, authorizations and/ or coding, then investment in denial prevention is advisable.
• Customize your recovery process. Give your recovery team work queues, deadlines and appeal templates so that your efforts are directed towards the right areas.

For most organizations, the information points towards one thing – the majority of their denials are preventable, hence denial prevention should attract larger amounts of investment.

How RapidClaims Supports Denial Prevention and Recovery

The majority of denials that could have been avoided begin from coding or documentation. RapidClaims applies AI-based medical coding and claims intelligence to assist practices in coding according to the current standards, identify any mistakes before claim submission and optimize their first pass yields.

RapidClaims will help organizations in analyzing the denial and prioritizing denials to know what needs to be fixed. Thus, the revenue cycle built on the principle of denials avoidance first, followed by effective denial recovery.

Final Thoughts

Prevention is the activity of solving problems associated with claims prior to submitting them to the insurance company. These problems include the verification of the eligibility and the benefits information of the patients, getting prior authorizations where needed, verifying the documents, using the proper codes and modifiers and then testing the claims prior to submission. The identification of the problems through denial trend analysis for each payer, service line, and reason codes will allow practices to solve the problems and avoid the repetitive denials.

Recovery is important since there will always be some denials which cannot be prevented and therefore the need to develop ways of handling them. However, there exist scenarios where the claims are denied despite their validity, owing to the problem associated with the insurer. This will aid the team in scheduling the prioritization of the claims along with the submission of required documents in time.

In 2026, the most successful cash flow practices will include those that adopt both the prevention and recovery approaches. This is because such practices will invest in prevention as a way of avoiding certain denials and then focus on recovery in the event of denials.

FAQs

1. Define denial prevention in medical billing.

Denial prevention is a strategy aimed at the prevention of claim denials prior to submission through verifying eligibility, prior authorizations, proper coding, appropriate documentation, and specific payer claim scrubbing.

2. Is denial prevention more effective financially than denial recovery?

Yes, it typically is. Denial prevention means not spending time and money on claim recovery procedures and protecting your revenue from being lost due to denied claims.

3. How can denial prevention success be measured?

The most important indicator of its success is first pass yield, which is the percentage of claims that are paid on first submission. Clean claim rate, denial rate, and average collection days should also be tracked.

4. Which denials occur most frequently and are avoidable? 

The most frequent are eligibility and coverage issues, lack of prior authorizations, inaccurate claim data, coding and modifier errors, lack of documentation of medical necessity, and untimely submission of the claim.

5. What role can AI play in the prevention of denials in 2026? 

AI technologies will be able to compare codes and modifiers with current regulations, tie diagnoses to the documentation, alert about potential denials based on past experience, and find necessary authorizations prior to the submission of the claim.